Found 39 matching trials
HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma
N/AHepatic arterial infusion chemotherapy (HAIC) plus lenvatinib and programme...
Location
Chinese PLA General hospital
Lenvatinib Plus Toripalimab for Platinum-Resistant Recurrent Ovarian Cancer
PHASE2The investigators propose to initiate a study assessing the efficacy and sa...
Location
Peking Union Medical College Hospital
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma
N/AThis study is conducted to evaluate the efficacy, prognosis, adverse effect...
Location
The Second Affiliated Hospital of Fujian Medical University
dTACE-HAIC Combined With Bevacizumab and Atezolizumab for Huge Hepatocellular Carcinoma
NAThis study intends to evaluate the efficacy and safety of drug-eluting tran...
Location
Chinese PLA General hospital
HAIC Combined With Bevacizumab and Toripalimab for Advanced Hepatocellular Carcinama
PHASE2This is an open-label, single-arm clinical study to preliminarily observe a...
Location
Multiple Locations
Phase III Study of Toripalimab(JS001) Combined With Lenvatinib for Advanced HCC
PHASE3This is a prospective, randomized, placebo-controlled, double-blind, multic...
Status
Active Not Recruiting
Location
Qinhuai Medical Area, General Hospital of PLA Eastern Theater Command
Anti-angiogenic Agents Plus Anti-PD-1 Antibodies for uHCC
N/ACombination treatment with antiangiogenic agents and anti-programmed cell d...
Location
Zhongshan Hospital, Fudan University
HAIC + DEB-TACE + Toripalimab + Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma
PHASE2Purpose: This phase II clinical trial evaluates whether a combination of li...
Location
Multiple Locations
Toripalimab in Combination With Lenvatinib as Neoadjuvant Therapy in Resectable Hepatocellular Carcinoma
PHASE1This study will evaluate efficacy and safety of Toripalimab Injection (JS00...
Location
Fudan University Zhongshan Hospital
Oncolytic Virus H101 Combined With Lenvatinib Plus Toripalimab Compared With FOLFOX in Patients With Advanced Biliary Tract Cancer (OPTIONS-06)
PHASE2This study will evaluate the efficacy and safety of Oncolytic virus H101 co...
Location
Zhongshan Hospital, Fudan University